Literature DB >> 1752005

Epinephrine-aminophylline-induced arrhythmias after midazolam or thiopentone in halothane-anaesthetized dogs.

A A Lina1, P J Dauchot, A H Anton.   

Abstract

The purpose of this study was to evaluate epinephrine-aminophylline-induced arrhythmias during halothane anaesthesia after induction with thiopentone or midazolam. Ten mongrel dogs were studied during 1 MAC halothane and 50% N2O:O2 anaesthesia while maintaining constant acid-base status. The minimal arrhythmogenic infusion rate of epinephrine (MAIRE) and the corresponding plasma concentration of epinephrine (MAPC) required to produce ventricular arrhythmias before and after aminophylline were higher following induction of anaesthesia with midazolam than with thiopentone (P less than 0.05); the MAIREs decreased stepwise with aminophylline (P less than 0.05). The correlation coefficient between individual MAIREs and MAPCs was 0.93 (P less than 0.001). Epinephrine alone and in combination with aminophylline was less arrhythmogenic after induction with midazolam than with thiopentone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752005     DOI: 10.1007/BF03008623

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  30 in total

Review 1.  Cardiac arrhythmias during anesthesia and operation.

Authors:  R L Katz; J T Bigger
Journal:  Anesthesiology       Date:  1970-08       Impact factor: 7.892

2.  Combined use of beta-adrenergic agonists and methyl xanthines.

Authors:  R A Nicklas; V E Whitehurst; R F Donohoe
Journal:  N Engl J Med       Date:  1982-08-26       Impact factor: 91.245

3.  Multiform ventricular tachycardia due to the interaction of aminophylline and halothane.

Authors:  M F Roizen; W C Stevens
Journal:  Anesth Analg       Date:  1978 Nov-Dec       Impact factor: 5.108

4.  Treatment of status asthmaticus with halothane.

Authors:  S H Schwartz
Journal:  JAMA       Date:  1984-05-25       Impact factor: 56.272

5.  Effect of thiopental induction on sympathetic activity.

Authors:  J T Joyce; M F Roizen; E I Eger
Journal:  Anesthesiology       Date:  1983-07       Impact factor: 7.892

6.  Thiobarbiturate-induced dysrhythmias: the role of heart rate and autonomic imbalance.

Authors:  W W Muir
Journal:  Am J Vet Res       Date:  1977-09       Impact factor: 1.156

7.  A simple, reliable and rapid method for increasing the responsiveness of the glassy carbon electrode (GCE) for the analysis of biogenic amines by high performance liquid chromatography with electrochemical detection (LCEC).

Authors:  A H Anton
Journal:  Life Sci       Date:  1984-07-02       Impact factor: 5.037

8.  Epinephrine-induced arrhythmias: effect of exogenous prostaglandins and prostaglandin synthesis inhibition during halothane-O2 anesthesia in the dog.

Authors:  N L Pace; A Ohmura; K C Wong
Journal:  Anesth Analg       Date:  1979 Sep-Oct       Impact factor: 5.108

9.  Alterations in the arrhythmogenic dose of epinephrine after adrenergic receptor blockade with prazosin, metoprolol, or yohimbine in halothane-xylazine-anesthetized dogs.

Authors:  W J Tranquilli; J C Thurmon; G J Benson
Journal:  Am J Vet Res       Date:  1986-01       Impact factor: 1.156

10.  Enflurane and halothane in status asthmaticus.

Authors:  M Echeverria; A W Gelb; H R Wexler; D Ahmad; P Kenefick
Journal:  Chest       Date:  1986-01       Impact factor: 9.410

View more
  3 in total

1.  It is not necessary to administer more than 10 micrograms.kg-1 of atropine to older children before succinylcholine.

Authors:  G D Shorten; B Bissonnette; E Hartley; W Nelson; A S Carr
Journal:  Can J Anaesth       Date:  1995-01       Impact factor: 5.063

2.  A canine model of sustained atrial fibrillation induced by rapid atrial pacing and phenylephrine.

Authors:  Anusak Kijtawornrat; Brian M Roche; Robert L Hamlin
Journal:  Comp Med       Date:  2008-10       Impact factor: 0.982

3.  Management of intraoperative bronchospasm.

Authors:  Indira Malik
Journal:  Indian J Anaesth       Date:  2011-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.